Orasis seals $30m Series C

Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company, has raised $30 million in Series C financing.

Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company, has raised $30 million in Series C financing. Bluestem Capital and Visionary Ventures led the round.

Source: Press Release